• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edgewise Therapeutics Inc (NQ: EWTX )

    33.32 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Edgewise Therapeutics Inc

    < Previous 1 2 3 4 Next >
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
    Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Crude Oil Gains Over 1%; Mobileye Global Shares Jump
    Via Benzinga
    Exposures Fossil Fuels
    Why Edgewise Therapeutics Stock Is Up 50% on Thursday
    One of the biopharma company's heart drugs performs as well as initially hoped. 
    Via The Motley Fool
    Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Edgewise Therapeutics: Q4 Earnings Insights
    Via Benzinga
    How Is The Market Feeling About Edgewise Therapeutics?
    Via Benzinga
    Edgewise Therapeutics: Q3 Earnings Insights
    Via Benzinga
    Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment
    Edgewise Therapeutics announced topline data from Phase 1 and Phase 2 trials of EDG-7500 for obstructive hypertrophic cardiomyopathy, showing the drug was well tolerated with reductions in LVOT... 
    Via Benzinga
    Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Edgewise Catapults On Surprise Victory In Cardiomyopathy; Cytokinetics Shares Dip
    Edgewise Therapeutics is trying to edge into a market already owned by Bristol Myers Squibb, just behind Cytokinetics. 
    Via Investor's Business Daily
    EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q2 2024
    EWTX stock results show that Edgewise Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    7 Small-Cap Stocks to Buy for Large-Scale Gains
    Although small-cap stocks are incredibly risky, their underappreciated nature potentially gives them a high performance ceiling. 
    Via InvestorPlace
    Stock Market News For July 23: Quick Takes On GE Aerospace, Boeing, Biotechs
    What sectors outperformed after Trump won the 2016 election, and which outperformed during his term? 
    Via Investor's Business Daily
    Topics Government
    Exposures Political
    Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
    Biogen has $8 billion to $10 billion in dry powder for acquisitions. Here are three names the company could examine. 
    Via Investor's Business Daily
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM. 
    Via Investor's Business Daily
    EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q1 2024
    EWTX stock results show that Edgewise Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
    Via Benzinga
    Insider Favorites: 7 Stocks with Bullish Buying Signals
    Although you’ll still want to conduct your due diligence, following the smart money into these insider favorite stocks is tempting. 
    Via InvestorPlace
    Insiders Buying Edgewise Therapeutics And 2 Other Stocks
    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. 
    Via Benzinga
    Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    What's Going On With Edgewise Therapeutics Stock?
    Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shares are trading higher Friday after the company announced the pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share. 
    Via Benzinga
    World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
    U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street
    Analysts have high hopes for these three innovation companies in 2024. 
    Via The Motley Fool
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... 
    Via Benzinga
    Speculator’s Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall
    Although betting against the bears is risky, the rewards for targeting short-squeeze stocks can also be stratospheric. 
    Via InvestorPlace
    NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
    U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.